These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21444677)

  • 61. ALCAM is indirectly modulated by miR-125b in MCF7 cells.
    Akman HB; Selcuklu SD; Donoghue MT; Akhavantabasi S; Sapmaz A; Spillane C; Yakicier MC; Erson-Bensan AE
    Tumour Biol; 2015 May; 36(5):3511-20. PubMed ID: 25539763
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.
    Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Ghaedi K
    BMC Mol Cell Biol; 2021 Feb; 22(1):10. PubMed ID: 33541259
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel inhibitory function of miR-125b in melanogenesis.
    Kim KH; Bin BH; Kim J; Dong SE; Park PJ; Choi H; Kim BJ; Yu SJ; Kang H; Kang HH; Cho EG; Lee TR
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):140-4. PubMed ID: 24118912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
    Ferracin M; Bassi C; Pedriali M; Pagotto S; D'Abundo L; Zagatti B; Corrà F; Musa G; Callegari E; Lupini L; Volpato S; Querzoli P; Negrini M
    Mol Cancer; 2013 Oct; 12(1):130. PubMed ID: 24165569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. miR-125b targets ARID3B in breast cancer cells.
    Akhavantabasi S; Sapmaz A; Tuna S; Erson-Bensan AE
    Cell Struct Funct; 2012; 37(1):27-38. PubMed ID: 22307404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells.
    Puissegur MP; Eichner R; Quelen C; Coyaud E; Mari B; Lebrigand K; Broccardo C; Nguyen-Khac F; Bousquet M; Brousset P
    Leukemia; 2012 Oct; 26(10):2224-32. PubMed ID: 22469780
    [TBL] [Abstract][Full Text] [Related]  

  • 67. miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer.
    Yang D; Zhan M; Chen T; Chen W; Zhang Y; Xu S; Yan J; Huang Q; Wang J
    Sci Rep; 2017 Mar; 7():43109. PubMed ID: 28256505
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer.
    Wang Y; Wei Y; Fan X; Zhang P; Wang P; Cheng S; Zhang J
    Thorac Cancer; 2020 Jun; 11(6):1613-1620. PubMed ID: 32291953
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A methylation-based regulatory network for microRNA 320a in chemoresistant breast cancer.
    He DX; Gu XT; Jiang L; Jin J; Ma X
    Mol Pharmacol; 2014 Nov; 86(5):536-47. PubMed ID: 25159093
    [TBL] [Abstract][Full Text] [Related]  

  • 70. StarD13 3'-untranslated region functions as a ceRNA for TP53INP1 in prohibiting migration and invasion of breast cancer cells by regulating miR-125b activity.
    Zheng L; Li X; Chou J; Xiang C; Guo Q; Zhang Z; Guo X; Gao L; Xing Y; Xi T
    Eur J Cell Biol; 2018 Jan; 97(1):23-31. PubMed ID: 29146309
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Involvement of methylation of MicroRNA-122, -125b and -106b in regulation of Cyclin G1, CAT-1 and STAT3 target genes in isoniazid-induced liver injury.
    Li Y; Ren Q; Zhu L; Li Y; Li J; Zhang Y; Zheng G; Han T; Sun S; Feng F
    BMC Pharmacol Toxicol; 2018 Mar; 19(1):11. PubMed ID: 29554950
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer.
    Wang QY; Zhou CX; Zhan MN; Tang J; Wang CL; Ma CN; He M; Chen GQ; He JR; Zhao Q
    Cell Death Dis; 2018 Jul; 9(7):752. PubMed ID: 29970901
    [TBL] [Abstract][Full Text] [Related]  

  • 73. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
    Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
    Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.
    Morelli E; Leone E; Cantafio ME; Di Martino MT; Amodio N; Biamonte L; Gullà A; Foresta U; Pitari MR; Botta C; Rossi M; Neri A; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
    Leukemia; 2015 Nov; 29(11):2173-83. PubMed ID: 25987254
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.
    Yang L; Huang S; Ma H; Wu X; Feng F
    Tumour Biol; 2017 Mar; 39(3):1010428317692249. PubMed ID: 28347246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of the transcription factor Ets1 in carcinoma.
    Dittmer J
    Semin Cancer Biol; 2015 Dec; 35():20-38. PubMed ID: 26392377
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer.
    Wang H; Tan G; Dong L; Cheng L; Li K; Wang Z; Luo H
    PLoS One; 2012; 7(4):e34210. PubMed ID: 22523546
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regulation of alphaB-crystallin gene expression by the transcription factor Ets1 in breast cancer.
    Bosman JD; Yehiely F; Evans JR; Cryns VL
    Breast Cancer Res Treat; 2010 Jan; 119(1):63-70. PubMed ID: 19205872
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.
    Saetrom P; Biesinger J; Li SM; Smith D; Thomas LF; Majzoub K; Rivas GE; Alluin J; Rossi JJ; Krontiris TG; Weitzel J; Daly MB; Benson AB; Kirkwood JM; O'Dwyer PJ; Sutphen R; Stewart JA; Johnson D; Larson GP
    Cancer Res; 2009 Sep; 69(18):7459-65. PubMed ID: 19738052
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MicroRNA-125b Interacts with Foxp3 to Induce Autophagy in Thyroid Cancer.
    Wang S; Wu J; Ren J; Vlantis AC; Li MY; Liu SYW; Ng EKW; Chan ABW; Luo DC; Liu Z; Guo W; Xue L; Ng SK; van Hasselt CA; Tong MCF; Chen GG
    Mol Ther; 2018 Sep; 26(9):2295-2303. PubMed ID: 30005868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.